According to the hormone receptor expression, HER2-positive breast cancers can be subdivided into ER+PR+HER2+ (TPBC), ER+PR-HER2+, ER-PR+HER2+ (very rare), and ER-PR-HER2+. Here, NR4A1 is linked to breast carcinoma.